Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Turnaround Potential
1279.6000 -16.90 (-1.30%)
NSE Mar 16, 2026 15:31 PM
Volume: 1.4M
 

1279.60
-1.30%
Phillip Capital
products, price erosion in base business and delay in third party order supply. Guides forhealthygrowthQ4onwardsledbynewlaunches 9 EBITDAaswellasearningperformancewasinlineofexpectations...
Aurobindo Pharma Ltd. is trading above all available SMAs
More from Aurobindo Pharma Ltd.
Recommended